The therapeutic range of Epoetin beta (Recormon) is wide and individual response to therapy must be considered when Epoetin beta (Recormon) treatment is initiated. Overdose can result in manifestations of an exaggerated pharmacodynamic effect, e.g. excessive erythropoiesis which may be associated with life-threatening complications of the cardiovascular system. In case of excessive hemoglobin levels, Epoetin beta (Recormon) should be temporarily withheld (see Dosage & Administration). If clinically indicated, phlebotomy may be performed.